Please assess the completion status of the following clinical trial:

Trial Title: Perioperative Ketamine for Pain With Gastric Bypass

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients undergoing laparoscopic gastric bypass at Mayo Clinic in Arizona~2. BMI is ≥ 35 kg/m2~3. Consent is able to be obtained as per Mayo Clinic policy~Exclusion Criteria:~1. Intolerance to ketamine~2. History of schizophrenia, schizoaffective disorder, or other psychiatric diagnosis with psychotic features~3. Presence of unstable cardiovascular disease (presence of acute coronary syndrome, unstable angina, hypertension emergency, acute transient ischemic attack (TIA) or stroke)~4. Presence of acute elevation of intracranial or intraocular pressure~5. Presence of seizure disorder~6. History of substance abuse or addiction~7. Creatinine greater than 1.5 mg/dL~8. End-stage liver disease~9. Pregnancy~10. Patients with chronic pain and/or chronic opioid therapy will not be excluded to more closely replicate the study patient population of interest. However, patients taking greater than 50 morphine equivalents (ME) per day for greater than 1 month prior to surgery will be excluded.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 69 Years
- Healthy Volunteers: t

Study Arms:
- Ketamine Therapy (Type: EXPERIMENTAL): 1. Ketamine 0.3 mg/kg (IBW) bolus with induction.~2. Ketamine infusion 0.2 mg/kg/hr. (IBW) initiated after induction and terminated after 24 hours.~3. Ketamine infusion will not be titrated.~4. Remaining care will be identical to standard therapy group.
- Standard Therapy (Type: ACTIVE_COMPARATOR): 1. Calculation ideal body weight (IBW)~2. Pre-op dexamethasone~3. Pre-op midazolam at discretion of anesthesiologist~4. Anesthesia Induction - Propofol and fentanyl, anesthesiologist discretion. Neuromuscular block with succinylcholine and/or rocuronium at discretion of anesthesiologist. Orotracheal intubation.~5. Anesthesia Maintenance - Sevoflurane/rocuronium. Addl. doses of fentanyl, discretion of anesthesiologist.~6. Emergence from anesthesia - Acetaminophen, Ketorolac and Ondansetron unless contraindicated. Sugammadex depending on twitch response per drug manufacturer recommended protocol.~7. Post-Op Analgesia - Hydromorphone, acetaminophen and ketorolac~8. Other post-op care as per usual surgical routine

Based on this trial design, predict the completion outcome and termination type (if applicable).